Leading flow cytometry platforms and expertise that enable reliable cell isolation for preclinical and clinical applications of any scale and complexity.
Fluorescence-activated cell sorting (FACS) is the gold standard for isolating discrete cell populations from complex biological samples. Our FACS services use high-speed cell sorters and a rigorous, GCLP-compliant approach, delivering greater than 95% pure cell populations with limited contamination.
Whether you are developing new biologics or characterizing disease pathology, our standardized protocols and expert team have the capacity to support your project from end-to-end.
FACS sorting can be performed across a broad range of clinical samples, including:
Our standardized FACS protocols and platforms can handle tissue samples of different origins, including human, cynomolgus monkey, and mouse.
CellCarta offers both off-the-shelf (OTS) and custom panels, allowing for the enrichment of any cell population of interest.
Our workflow is highly adaptable, where cells can be identified by any fluorescence label, including fluorescent antibodies, signaling dyes, proliferation dyes, and viability dyes.
Our FACS sorting goes beyond standard analysis. We can use up to 12 parameters to define your cell population, ensuring high-purity isolation. Furthermore, not only are cells sorted by marker, but they can be sorted based on expression levels, allowing for rare subset identification.
Up to four cell populations can be sorted at once using our instruments equipped with four lasers (RGBV), making it a suitable choice for industrial applications.
Before sorting begins, our team of immunologists can assist with assay design and setup. We offer a wide range of pre-sorting assays to optimize your data, including:
Quality is always a priority for CellCarta. Following each sort, purity and viability checks are performed to ensure sample integrity is maintained for all downstream applications.
Following FACS sorting, we deliver an end-product suitable for your study's objectives, including:
Using our CellEngine software, our team can assist with final data analysis and reporting.
FACS sorting can be performed across a broad range of clinical samples, including:
Our standardized FACS protocols and platforms can handle tissue samples of different origins, including human, cynomolgus monkey, and mouse.
CellCarta offers both off-the-shelf (OTS) and custom panels, allowing for the enrichment of any cell population of interest.
Our workflow is highly adaptable, where cells can be identified by any fluorescence label, including fluorescent antibodies, signaling dyes, proliferation dyes, and viability dyes.
Our FACS sorting goes beyond standard analysis. We can use up to 12 parameters to define your cell population, ensuring high-purity isolation. Furthermore, not only are cells sorted by marker, but they can be sorted based on expression levels, allowing for rare subset identification.
Up to four cell populations can be sorted at once using our instruments equipped with four lasers (RGBV), making it a suitable choice for industrial applications.
Before sorting begins, our team of immunologists can assist with assay design and setup. We offer a wide range of pre-sorting assays to optimize your data, including:
Quality is always a priority for CellCarta. Following each sort, purity and viability checks are performed to ensure sample integrity is maintained for all downstream applications.
Following FACS sorting, we deliver an end-product suitable for your study's objectives, including:
Using our CellEngine software, our team can assist with final data analysis and reporting.
CellCarta’s fluorescence-activated cell sorting services deliver cells of the highest purity. This ensures support for genomic and transcriptomic analysis, single-cell plating, co-culture assays, isolation of tetramer-positive cells, purification of transfected cell lines, and stocking of rare cells.
From panel design to purified population: precision, compliance, and expertise at every stage.
High-Purity Isolation
Adaptable Workflows
High-Throughput Capacity
Cutting-Edge Technology
Rigorous QA/QC
Beginning with FACS sorting, our vast service offerings can be incorporated for complete downstream processing of your samples.
Our fluorescence-activated cell sorting service supports a broad range of inputs, including whole blood, PBMCs, stem cells, bone marrow aspirates, and tumor cells from clinical samples; tissue samples of human, cynomolgus monkey, and mouse origin; in vitro expanded primary cells; and suspension cell lines. If you are unsure whether your specific sample type is compatible, our flow cytometry team can advise during our initial consultation.
Our instruments are capable of sorting up to four populations simultaneously in a single run. Each target population can be defined by up to 12 parameters, and sorting can be based on expression level (low, mid, or high), enabling the isolation of rare cell subpopulations.
CellCarta’s FACS service is designed to meet clinical program requirements. When required, a rigorous GCLP-compliant approach is applied across the full workflow. Flow cytometry specialists engage from initial assay planning through data analysis and reporting, providing a single accountable team for every deliverable. Post-sort purity and viability checks are performed after each run, generating documented quality records that support submission requirements without additional internal QC burden on your team.
Yes. Both standard and custom panels are supported. Cells can be identified using any fluorescence label, including fluorescent antibodies, signaling dyes, proliferation dyes, and viability dyes, and sorted based on expression level (low, mid, or high).
Sorted populations are available in three delivery formats: cryopreserved, freshly isolated, or fixed. The appropriate format is determined by the requirements of your downstream application, including genomic or transcriptomic analysis, single-cell plating, co-culture assays, isolation of tetramer-positive cells, purification of transfected cell lines, or stocking of rare cell types. Our team confirms the right delivery format for your study before the sort begins, ensuring the end product is ready for immediate use in the next stage of your study.